SOCS1 Is a Critical Inhibitor of Interferon γ Signaling and Prevents the Potentially Fatal Neonatal Actions of this Cytokine
暂无分享,去创建一个
Paul J Hertzog | Donald Metcalf | Warren S Alexander | Douglas J Hilton | C. Scott | W. Alexander | D. Hilton | P. Hertzog | T. Kay | R. Darwiche | C. Owczarek | N. Nicola | E. Handman | D. Metcalf | Nicos A Nicola | Clare L Scott | R. Starr | J. Corbin | Robyn Starr | Jennifer E Fenner | Emanuela Handman | Naomi S Sprigg | Jason E Corbin | Ann L Cornish | Rima Darwiche | Catherine M Owczarek | Thomas W.H Kay | A. L. Cornish | N. Sprigg | Jennifer E. Fenner
[1] A. Thomson. The cytokine handbook , 1994 .
[2] Takaho A. Endo,et al. A new protein containing an SH2 domain that inhibits JAK kinases , 1997, Nature.
[3] A. Billiau,et al. Interferon-gamma: biology and role in pathogenesis. , 1996, Advances in immunology.
[4] J. Darnell,et al. Activation of transcription by IFN-gamma: tyrosine phosphorylation of a 91-kD DNA binding protein. , 1992, Science.
[5] K Yuge,et al. A Janus kinase inhibitor, JAB, is an interferon-gamma-inducible gene and confers resistance to interferons. , 1998, Blood.
[6] K. Yamamura,et al. Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[7] T. Taniguchi,et al. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development , 1993, Cell.
[8] O. Silvennoinen,et al. Signaling by the cytokine receptor superfamily: JAKs and STATs. , 1994, Trends in biochemical sciences.
[9] W. Paul,et al. Interleukin-4 : A Prototypic Immunoregulatory Lymphokine , 2003 .
[10] J. D. de Vries,et al. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. , 1994, Immunology today.
[11] K. Okkenhaug,et al. Socs1 binds to multiple signalling proteins and suppresses Steel factor‐dependent proliferation , 1999, The EMBO journal.
[12] I. Mackay,et al. Intermittent interferonemia and interferon responses in multiple sclerosis. , 1991, Clinical immunology and immunopathology.
[13] R. Simpson,et al. Role of interleukin-6 in T-cell activation during primary and secondary infection with Listeria monocytogenes , 1995, Infection and immunity.
[14] S. Cohen,et al. Induction by EGF and interferon-gamma of tyrosine phosphorylated DNA binding proteins in mouse liver nuclei. , 1993, Science.
[15] J. Ihle,et al. Signaling by the Cytokine Receptor Superfamily a , 1998, Annals of the New York Academy of Sciences.
[16] J. Darnell,et al. Contribution of STAT SH2 groups to specific interferon signaling by the Jak-STAT pathway , 1995, Science.
[17] W. Alexander,et al. Point mutations within a dimer interface homology domain of c‐Mpl induce constitutive receptor activity and tumorigenicity. , 1995, The EMBO journal.
[18] W. Leonard,et al. Jaks and STATs: biological implications. , 1998, Annual review of immunology.
[19] B. Viviano,et al. Ligand‐induced IFN gamma receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91). , 1994, The EMBO journal.
[20] J. Darnell,et al. Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions , 1994, Cell.
[21] J. Darnell,et al. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. , 1995, Annual review of biochemistry.
[22] S. Corey,et al. Src-related protein tyrosine kinases in hematopoiesis. , 1999, Blood.
[23] M. Ferguson,et al. Biosynthesis of the glycolipid anchor of lipophosphoglycan and the structurally related glycoinositolphospholipids from Leishmania major. , 1995, The Biochemical journal.
[24] F. Chisari,et al. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis , 1993, The Journal of experimental medicine.
[25] A. Billiau,et al. Cytokines and their interactions with other inflammatory mediators in the pathogenesis of sepsis and septic shock , 1991, European journal of clinical investigation.
[26] D. Levy,et al. Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease , 1996, Cell.
[27] W. Fiers,et al. Toxic effects of recombinant tumor necrosis factor in suckling mice. Comparisons with interferon alpha/beta. , 1987, The American journal of pathology.
[28] A. Wilks,et al. Interferon-gamma induces tyrosine phosphorylation of interferon-gamma receptor and regulated association of protein tyrosine kinases, Jak1 and Jak2, with its receptor. , 1994, The Journal of biological chemistry.
[29] J. Darnell,et al. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. , 1994, Science.
[30] G. Stark,et al. Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon‐alpha and ‐gamma signal transduction pathways. , 1993, The EMBO journal.
[31] A. Bradley,et al. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. , 1993, Science.
[32] W. Alexander,et al. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL‐6 signal transduction , 1999, The EMBO journal.
[33] R. Schreiber,et al. IFN-gamma action on pancreatic beta cells causes class I MHC upregulation but not diabetes. , 1998, The Journal of clinical investigation.
[34] S. Pestka,et al. Targeted disruption of the interferon-gamma receptor 2 gene results in severe immune defects in mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[35] S. Melmed,et al. Pituitary corticotroph SOCS-3: novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion. , 1998, Molecular endocrinology.
[36] A. Yoshimura,et al. CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. , 1997, Blood.
[37] E. Handman. Association of serum proteins with cultured Leishmanial a warning note , 1983, Parasite immunology.
[38] A. Elefanty,et al. Aberrant hematopoiesis in mice with inactivation of the gene encoding SOCS-1 , 1999, Leukemia.
[39] G. Stark,et al. The protein tyrosine kinase JAK1 complements defects in interferon-α/β and -γ signal transduction , 1993, Nature.
[40] I. Gresser. Can interferon induce disease? , 1982, Interferon.
[41] J. A. Acree. On mutation , 1980 .
[42] M Aguet,et al. The IFN gamma receptor: a paradigm for cytokine receptor signaling. , 1997, Annual review of immunology.
[43] M. Aguet,et al. A novel member of the interferon receptor family complements functionality of the murine interferon γ receptor in human cells , 1994, Cell.
[44] A. Wilks,et al. Colony-stimulating factor 1-induced STAT1 and STAT3 activation is accompanied by phosphorylation of Tyk2 in macrophages and Tyk2 and JAK1 in fibroblasts. , 1995, Blood.
[45] R. Schreiber,et al. Targeted Disruption of the Stat1 Gene in Mice Reveals Unexpected Physiologic Specificity in the JAK–STAT Signaling Pathway , 1996, Cell.
[46] W. Paul. Interleukin-4: a prototypic immunoregulatory lymphokine. , 1991, Blood.
[47] D. Hilton,et al. Growth Hormone Preferentially Induces the Rapid, Transient Expression of SOCS-3, a Novel Inhibitor of Cytokine Receptor Signaling* , 1998, The Journal of Biological Chemistry.
[48] T. Taniguchi,et al. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. , 1994, Science.
[49] J. Flier,et al. Identification of SOCS-3 as a potential mediator of central leptin resistance. , 1998, Molecular cell.
[50] H. Dickensheets,et al. Interleukin-10 Inhibits Expression of Both Interferon – and Interferon γ– Induced Genes by Suppressing Tyrosine Phosphorylation of STAT1 , 1999 .
[51] U. Boehm,et al. Cellular responses to interferon-gamma. , 1997, Annual review of immunology.
[52] M. Newport,et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. , 1996, The New England journal of medicine.
[53] Suzanne Cory,et al. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship , 1991, Cell.
[54] J. Darnell. STATs and gene regulation. , 1997, Science.
[55] M. Aguet,et al. Electrophoretically pure mouse interferon inhibits growth, induces liver and kidney lesions, and kills suckling mice. , 1981, The American journal of pathology.
[56] G. Stark,et al. Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-& gamma; signal transduction pathway , 1993, Nature.
[57] K. Shuai,et al. The Suppressor of Cytokine Signaling (SOCS) 1 and SOCS3 but Not SOCS2 Proteins Inhibit Interferon-mediated Antiviral and Antiproliferative Activities* , 1998, The Journal of Biological Chemistry.
[58] J. Ihle,et al. Naturally occurring dominant negative variants of Stat5 , 1996, Molecular and cellular biology.
[59] S. Akira,et al. Structure and function of a new STAT-induced STAT inhibitor , 1997, Nature.
[60] C. Nathan,et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase , 1995, Cell.
[61] B. Cohen,et al. The human interferon α β receptor: Characterization and molecular cloning , 1994, Cell.
[62] A. Billiau,et al. Anti-gamma interferon and anti-interleukin-6 antibodies affect staphylococcal enterotoxin B-induced weight loss, hypoglycemia, and cytokine release in D-galactosamine-sensitized and unsensitized mice , 1995, Infection and immunity.
[63] A. Elefanty,et al. Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[64] Warren S. Alexander,et al. A family of cytokine-inducible inhibitors of signalling , 1997, Nature.
[65] K. Ozato,et al. MONOCLONAL ANTIBODIES TO MOUSE MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENS: IV. A SERIES OF HYBRIDOMA CLONES PRODUCING ANTI‐H-2d ANTIBODIES AND AN EXAMINATION OF EXPRESSION OF H‐2d ANTIGENS ON THE SURFACE OF THESE CELLS , 1982, Transplantation.
[66] W. Alexander,et al. Twenty proteins containing a C-terminal SOCS box form five structural classes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[67] P. Massa,et al. The role of protein tyrosine phosphatase SHP-1 in the regulation of IFN-gamma signaling in neural cells. , 1996, Journal of immunology.
[68] R. Zinkernagel,et al. Immune response in mice that lack the interferon-gamma receptor. , 1993, Science.
[69] R. Tatake,et al. Regulated Expression of the Major Histocompatibility Complex Class I Genes , 1993, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.